Company intelligence / Profile preview

GL Biochem

Shanghai, Shanghai, Chinaglbiochem.com ↗

Ownership: Private
Development stage: Commercial

Overview

GL Biochem operates at commercial scale as one of the world’s largest custom peptide manufacturers. They do not have their own clinical pipeline but support global R&D with high-quality peptides and antibodies. Their products are used in preclinical through commercial applications by clients worldwide

Therapeutic areas: Other
Modalities: PeptidesAntibodySmall moleculeAmino acids and derivatives
Industry: Contract Manufacturing Organization

Partnerships

Not specifically listed; serves major pharmaceutical companies, biotech firms, universities globally

Beyond the preview

Go deeper on GL Biochem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GL Biochem.

Explore the full profile